Pages that link to "Q49497789"
Jump to navigation
Jump to search
The following pages link to Elke Schaeffeler (Q49497789):
Displaying 50 items.
- Reduced Paneth cell alpha-defensins in ileal Crohn's disease (Q24538724) (← links)
- Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study (Q24633579) (← links)
- A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon (Q24678661) (← links)
- Expression and localization of the multidrug resistance protein 5 (MRP5/ABCC5), a cellular export pump for cyclic nucleotides, in human heart (Q24685159) (← links)
- Activating mutation of the renal epithelial chloride channel ClC-Kb, predisposing to hypertension (Q28262218) (← links)
- High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1) (Q28269517) (← links)
- DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma (Q28383720) (← links)
- Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs) (Q28479037) (← links)
- CYP3A5 genotype is associated with diagnosis of hypertension in elderly patients: data from the DEBATE Study (Q30991959) (← links)
- Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C19: evidence from clinical and pharmacokinetic data (Q31024434) (← links)
- MALDI-TOF mass spectrometry for multiplex genotyping of CYP2B6 single-nucleotide polymorphisms (Q33262580) (← links)
- Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: reliable genotyping in different ethnic groups (Q33358619) (← links)
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation (Q33368192) (← links)
- Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease (Q33409853) (← links)
- Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation (Q33431427) (← links)
- Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver (Q33480591) (← links)
- A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease (Q33510148) (← links)
- Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk (Q33634168) (← links)
- A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens (Q33677062) (← links)
- Translational learning from clinical studies predicts drug pharmacokinetics across patient populations (Q33767468) (← links)
- PXR variants and artemisinin use in Vietnamese subjects: frequency distribution and impact on the interindividual variability of CYP3A induction by artemisinin (Q34129977) (← links)
- Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease (Q34185576) (← links)
- Mechanisms and assessment of statin-related muscular adverse effects (Q34570995) (← links)
- Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE). (Q35208684) (← links)
- MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine (Q35803858) (← links)
- SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease (Q36126656) (← links)
- Pharmacogenomics: a key component of personalized therapy (Q36632885) (← links)
- Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing (Q36747429) (← links)
- Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease (Q36836028) (← links)
- Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach (Q36875975) (← links)
- Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1 (Q36998199) (← links)
- Nomenclature for alleles of the thiopurine methyltransferase gene (Q37056505) (← links)
- Maternal eNOS deficiency determines a fatty liver phenotype of the offspring in a sex dependent manner (Q37082705) (← links)
- Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes (Q37110909) (← links)
- Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1). (Q37598626) (← links)
- Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics (Q37933394) (← links)
- Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs (Q38042679) (← links)
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects (Q38070652) (← links)
- Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research (Q38176406) (← links)
- Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature (Q38414396) (← links)
- Functional genomics suggest neurogenesis in the adult human olfactory bulb (Q38487175) (← links)
- Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis (Q38729821) (← links)
- Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy (Q38816602) (← links)
- Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine (Q38831370) (← links)
- Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors (Q38962195) (← links)
- Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison (Q39089162) (← links)
- Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression (Q40006151) (← links)
- Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver (Q40028874) (← links)
- A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis (Q40375488) (← links)
- Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. (Q40447949) (← links)